These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6739701)

  • 1. Incidence of tardive dyskinesia in an outpatient population.
    Yassa R; Nair V
    Psychosomatics; 1984 Jun; 25(6):479-81. PubMed ID: 6739701
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC; Root L; Marmion J; Molinari V; Adams GL
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the prevalence of severe tardive dyskinesia.
    Smith JM; Dunn DD
    Am J Psychiatry; 1979 Aug; 136(8):1080-2. PubMed ID: 464137
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tardive dyskinesia: five-year data from a prospective study.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    Psychopharmacol Bull; 1984; 20(1):39-40. PubMed ID: 6144134
    [No Abstract]   [Full Text] [Related]  

  • 7. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of tardive dyskinesia: five-year data from a prospective study.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B; Borenstein M
    Psychopharmacol Bull; 1984; 20(3):387-9. PubMed ID: 6473637
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J;
    Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of tardive dyskinesia.
    Tepper SJ; Haas JF
    J Clin Psychiatry; 1979 Dec; 40(12):508-16. PubMed ID: 40964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population.
    Glazer WM; Morgenstern H
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):10S-16S. PubMed ID: 3065363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM; Morgenstern H; Doucette JT
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: characterization and prevalence in a statewide system.
    Bell RC; Smith RC
    J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases.
    Chouinard G; Annable L; Ross-Chouinard A; Mercier P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics.
    Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV
    Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.